Rare Disease Drug Sales to Exceed $400 Billion by 2032
Rare Disease Drugs Drive Pharma Growth Despite Challenges The rare disease drug market is on track for remarkable expansion, with
Continue ReadingTag: pharma competition
Patent Expirations Set Biopharma on a Tough Path for 2026
Biopharma Faces a Critical Year Ahead The biopharma industry is entering 2026 with uncertainty, as patent expirations on blockbuster drugs
Continue Reading